SUPN logo

Supernus Pharmaceuticals (SUPN) Retained earnings

annual retained earnings:

$556.43M+$73.86M(+15.31%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual retained earnings is $556.43 million, with the most recent change of +$73.86 million (+15.31%) on December 31, 2024.
  • During the last 3 years, SUPN annual retained earnings has risen by +$176.50 million (+46.46%).
  • SUPN annual retained earnings is now at all-time high.

Performance

SUPN Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly retained earnings:

$544.60M-$11.83M(-2.13%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly retained earnings is $544.60 million, with the most recent change of -$11.83 million (-2.13%) on March 31, 2025.
  • Over the past year, SUPN quarterly retained earnings has increased by +$61.91 million (+12.83%).
  • SUPN quarterly retained earnings is now -2.13% below its all-time high of $556.43 million, reached on December 31, 2024.

Performance

SUPN quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SUPN Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+15.3%+12.8%
3 y3 years+46.5%+22.1%
5 y5 years+178.8%+146.3%

SUPN Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+46.5%-2.1%+22.1%
5 y5-yearat high+178.8%-2.1%+146.3%
alltimeall timeat high+393.7%-2.1%+380.6%

SUPN Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$544.60M(-2.1%)
Dec 2024
$556.43M(+15.3%)
$556.43M(+2.8%)
Sep 2024
-
$541.10M(+7.7%)
Jun 2024
-
$502.60M(+4.1%)
Mar 2024
-
$482.69M(+0.0%)
Dec 2023
$482.56M(+0.3%)
$482.56M(+0.2%)
Sep 2023
-
$481.39M(-3.2%)
Jun 2023
-
$497.36M(-0.2%)
Mar 2023
-
$498.19M(+3.5%)
Dec 2022
$481.25M(+26.7%)
$481.25M(+5.6%)
Sep 2022
-
$455.76M(+0.4%)
Jun 2022
-
$454.01M(+1.8%)
Mar 2022
-
$446.15M(+17.4%)
Dec 2021
$379.92M(+16.4%)
$379.92M(+0.6%)
Sep 2021
-
$377.48M(+6.1%)
Jun 2021
-
$355.92M(+7.1%)
Mar 2021
-
$332.19M(+1.7%)
Dec 2020
$326.50M(+63.6%)
$326.50M(+10.4%)
Sep 2020
-
$295.73M(+15.6%)
Jun 2020
-
$255.73M(+15.7%)
Mar 2020
-
$221.07M(+10.8%)
Dec 2019
$199.55M(+130.7%)
$199.55M(+19.9%)
Sep 2019
-
$166.42M(+21.0%)
Jun 2019
-
$137.56M(+31.2%)
Mar 2019
-
$104.83M(+21.2%)
Dec 2018
$86.49M(-422.5%)
$86.49M(+42.7%)
Sep 2018
-
$60.60M(+86.0%)
Jun 2018
-
$32.59M(+1660.6%)
Mar 2018
-
$1.85M(-106.9%)
DateAnnualQuarterly
Dec 2017
-$26.82M(-68.2%)
-$26.82M(-33.7%)
Sep 2017
-
-$40.48M(-28.3%)
Jun 2017
-
-$56.44M(-23.5%)
Mar 2017
-
-$73.81M(-12.4%)
Dec 2016
-$84.29M(-52.0%)
-$84.29M(-14.5%)
Sep 2016
-
-$98.61M(-23.9%)
Jun 2016
-
-$129.64M(-7.2%)
Mar 2016
-
-$139.65M(-20.4%)
Dec 2015
-$175.51M(-7.4%)
-$175.51M(+15.8%)
Sep 2015
-
-$151.51M(-2.7%)
Jun 2015
-
-$155.73M(-1.3%)
Mar 2015
-
-$157.74M(-16.7%)
Dec 2014
-$189.45M(+6.1%)
-$189.45M(+16.2%)
Sep 2014
-
-$163.01M(-14.6%)
Jun 2014
-
-$190.87M(-1.6%)
Mar 2014
-
-$194.07M(+8.7%)
Dec 2013
-$178.53M(+107.0%)
-$178.53M(+14.4%)
Sep 2013
-
-$156.12M(+18.3%)
Jun 2013
-
-$132.03M(+26.1%)
Mar 2013
-
-$104.67M(+21.3%)
Dec 2012
-$86.25M(+115.8%)
-$86.25M(+18.6%)
Sep 2012
-
-$72.74M(+22.8%)
Jun 2012
-
-$59.26M(+20.3%)
Mar 2012
-
-$49.25M(+23.2%)
Dec 2011
-$39.97M(-57.4%)
-$39.97M(-67.2%)
Sep 2011
-
-$121.95M(+30.0%)
Dec 2010
-$93.79M(+69.5%)
-$93.79M(+10.1%)
Sep 2010
-
-$85.21M(+54.0%)
Dec 2009
-$55.32M(-0.8%)
-$55.32M
Dec 2008
-$55.78M
-

FAQ

  • What is Supernus Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual retained earnings year-on-year change?
  • What is Supernus Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly retained earnings year-on-year change?

What is Supernus Pharmaceuticals annual retained earnings?

The current annual retained earnings of SUPN is $556.43M

What is the all time high annual retained earnings for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual retained earnings is $556.43M

What is Supernus Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, SUPN annual retained earnings has changed by +$73.86M (+15.31%)

What is Supernus Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of SUPN is $544.60M

What is the all time high quarterly retained earnings for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly retained earnings is $556.43M

What is Supernus Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, SUPN quarterly retained earnings has changed by +$61.91M (+12.83%)
On this page